Bausch Health Companies | VRX - Srodki Pieniężne I Ekwiwalent

Cena Akcji
7.37
Dzienna Zmiana
0.04 0.55%
Miesięcznie
-6.59%
Rocznie
13.21%
Q2 Prognozy TE
7.72




Srodki Pieniężne I Ekwiwalent Zmiana Data
Amgen USD 12.04B 2.91B 2026-03
ANI Pharmaceuticals USD 311.18M 25.59M 2026-03
Aurora Cannabis CAD 56.36M 39.33M 2025-12
Bausch Health Companies USD 1.31B 1000K 2025-12
Biogen USD 3.38B 374.2M 2026-03
Bristol-Myers Squibb USD 9.57B 635M 2026-03
Canopy Growth CAD 371.32M 73.26M 2025-12
Corcept Therapeutics USD 108.74M 11.76M 2026-03
Danaher USD 5.7B 1.09B 2026-03
Drreddys Laboratories INR 18.66B 9.65B 2025-12
Eli Lilly USD 5.28B 1.99B 2026-03
Gilead Sciences USD 7.56B 234M 2025-12
Nektar Therapeutics USD 15.12M 25.92M 2025-12
Novo Nordisk A/S DKK 18.44B 5.78B 2025-06
Pacira USD 144.31M 14.24M 2026-03
Perrigo USD 531.6M 99.5M 2025-12
Phibro Animal Health USD 54.93M 557K 2026-03
Prestige Brands USD 62.37M 56.73M 2025-12
Supernus Pharmaceuticals USD 184.87M 56.42M 2026-03
Vertex Pharmaceuticals USD 7.25B 638.6M 2026-03
Zoetis USD 1.94B 369M 2026-03